AC Immune SA (ACIU) Stock Statistics & Valuation Metrics

AC Immune SA has a market cap or net worth of $264.61M. The enterprise value is $175.44M.

AC Immune SA has 101,773,575 shares outstanding. The number of shares has decreased by -2.65% in one year.

AC Immune SA’s return on equity (ROE) is -1.57 and return on invested capital (ROIC) is -113.86%.

The current PE Ratio of AC Immune SA is ―. AC Immune SA’s PEG ratio is -0.10.

In the last 12 months, AC Immune SA had revenue of 3.57M and earned -70.45M in profits. Earnings per share was -0.70.

In the last 12 months, operating cash flow was -50.39M and capital expenditures -538.16K, giving a free cash flow of -50.92M billion.

AC Immune SA pays an annual dividend of ―, resulting in a dividend yield of ―

AC Immune SA upcoming earnings date is Jul 30, 2026, TBA (Confirmed).

AC Immune SA as a current ratio of 1.02, with Debt / Equity ratio of 13.65%

In the past 12 months, AC Immune SA has paid 0.00 in taxes.

AC Immune SA EV to EBITDA ratio is -3.37, with an EV/FCF ratio of -3.41.

AC Immune SA has $74.80M in cash and marketable securities with $4.30M in debt, giving a net cash position of $70.49M billion.

Gross margin is 100.00%, with operating margin of -1927.32%, and net profit margin of -1971.65%.

The average price target for AC Immune SA is $12.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy